Lupin Pharma Metformin Hydrochloride Tablet Recall [US]


Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls certain batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/GfnZ30qQfdN

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

  • Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a batch/lot of G901203, an expiry date of 12/2020 and a NDC 68180-336-07

Please consult the photograph above for details of the drug’s packaging, design and retail/wholesale presentation.

==> No barcodes, DINs, UPCs, item numbers, best-before date codes, manufacturing date codes, production dates, regulatory approval designations, registration numbers, agency approval designations or other identification numbers were listed with this recall notification.

According to the FDA, the affected Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, batch/lots were distributed nationwide in the US directly to Wholesalers, Distributors, Retailers and Repackagers. You should neither serve nor consume the recalled Metformin medications identified above.

Pharmacies should cease dispensing these identified medications. Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, and mail order pharmacies by phone and through recall notification and is arranging for the return of all the recalled product batch/lot. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg are advised to continue taking their medication and contact their pharmacist, physician or medical provider for advice regarding an alternative treatment.

==> Never stop taking your prescription medications, including Metformin Hydrochloride, without the knowledge and approval of your personal physician or other MD familiar with your medical history, current health status and other drugs, medications and supplements you may be consuming. Failure to do so, may result in a serious drug interaction, side effect, complication, personal injury and/or death.

==> You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

==> If you have a medical emergency, please contact 9-1-1, your closest hospital or emergency center equipped to properly treat N-Nitrosodimethylamine (“NDMA”) contamination.

==> To see other recalls and notifications caused by contaminated, adulterated or mislabeled Metformin Hydrochloride Extended Release Tablets, please search for “Metformin” using the Search Box at the top of this page.

Customers and patients with medical-related questions, who wish to report an adverse event, or quality issues about the Lupin Pharma products being recalled should contact Inmar Rx Solutions, Inc. toll-free at 1-855-532-1856. Staffed calls are received from 9:00 AM to 5:00 PM Eastern Standard Time, Monday to Friday. For reimbursement, please have the recalled batch/lot returned to Inmar Rx Solutions, Inc. The batch/lot number can be found on the side of the bottle.

==> To see other recalls and notifications caused by suspected faulty and/or dangerous Metformin Hydrochloride Extended Release Tablets, please search for “Metformin” using the Search Box at the top of this page.

==> To see other recalls and notifications caused by suspected N-Nitrosodimethylamine contamination contamination, please search for “NDMA” using the Search Box at the top of this page.

==> To see other recalls and notifications for products manufactured, marketed and/or sold by Lupin Pharmaceuticals, Inc., please search for “Lupin” using the Search Box at the top of this page.

==> To see other recalls and notifications caused by suspected Carcinogenic contamination, please search for “Cancer” using the Search Box at the top of this page.

___________________________________________________________

More information about this recall:
Recalls Direct RIN: 13139-2020
Want to read more about this recall?
==> Please click on the links above to visit the originating site.
Want to read more about other recalls?
==> Please click on the links below.

General information:
More recalls? Back to the main Recalls Direct page:
==> http://www.RecallsDirect.com/
About the Recalls Direct service:
==> http://wp.me/P2bVty-2
Visit the Living Safely site:
==> http://www.LivingSafely.org/
Report an unsafe food or drug you purchased in the US [external: new window opens]:
==> http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm095859.htm
Search for a recalled food or drug on the US FDA Web archive [external: new window opens]:
==> http://www.fda.gov/Safety/Recalls/ArchiveRecalls/default.htm

We welcome your feedback:
Want to e-mail or share this recall?
==> Simply use the “Share this” options below.
Is this recall relevant to you? Please let us know!
==> Click on the “Like” button below.
E. & O. E.

___________________________________________________________

%d bloggers like this: